-
Loading metrics
Open Access
Peer-reviewed
Research Article
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
-
Fiona Kerr,
Current address: School of Applied Sciences, Edinburgh Napier University, 9 Sighthill Court, Edinburgh, United Kingdom
Affiliation Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom
⨯ -
Oyinkan Sofola-Adesakin,
Affiliation Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom
⨯ -
Dobril K. Ivanov ,
Contributed equally to this work with: Dobril K. Ivanov, Jemma Gatliff
Affiliation European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
⨯ -
Jemma Gatliff ,
Contributed equally to this work with: Dobril K. Ivanov, Jemma Gatliff
Affiliation UCL School of Pharmacy, University College London, 29/39 Brunswick Square, London, United Kingdom
⨯ -
Beatriz Gomez Perez-Nievas,
Affiliation Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
⨯ -
Hélène C. Bertrand,
Affiliation UCL School of Pharmacy, University College London, 29/39 Brunswick Square, London, United Kingdom
⨯ -
Pedro Martinez †,
† Deceased.
Affiliation Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom
⨯ -
Rebecca Callard,
Affiliations Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom, Max Planck Institute for Biology of Ageing, Köln, Germany
⨯ -
Inge Snoeren,
Affiliations Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom, Max Planck Institute for Biology of Ageing, Köln, Germany
⨯ -
Helena M. Cochemé,
Affiliation MRC London Institute of Medical Sciences, Imperial College London, Du Cane Road, London, United Kingdom
⨯ -
Jennifer Adcott,
Affiliation Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom
⨯ -
Mobina Khericha,
Affiliations Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom, Max Planck Institute for Biology of Ageing, Köln, Germany
⨯ -
Jorge Iván Castillo-Quan,
Affiliations Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom, Max Planck Institute for Biology of Ageing, Köln, Germany
⨯ -
Geoffrey Wells,
Affiliation UCL School of Pharmacy, University College London, 29/39 Brunswick Square, London, United Kingdom
⨯ -
Wendy Noble,
Affiliation Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, United Kingdom
⨯ -
Janet Thornton,
Affiliation European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
⨯ - [ ... ],
-
Linda Partridge
* E-mail: partridge@age.mpg.de, l.partridge@ucl.ac.uk
Affiliations Institute of Healthy Ageing, and GEE, University College London, Darwin Building, Gower Street, London, United Kingdom, Max Planck Institute for Biology of Ageing, Köln, Germany
⨯ - [ view all ]
- [ view less ]
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
- Fiona Kerr,
- Oyinkan Sofola-Adesakin,
- Dobril K. Ivanov,
- Jemma Gatliff,
- Beatriz Gomez Perez-Nievas,
- Hélène C. Bertrand,
- Pedro Martinez,
- Rebecca Callard,
- Inge Snoeren,
- Helena M. Cochemé
- Published: March 2, 2017
- https://doi.org/10.1371/journal.pgen.1006593